Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

302 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share as of Q1 2025.
Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) has 258 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 72.2M shares of 84.8M outstanding shares and own 85.16% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.56M shares), JANUS HENDERSON GROUP PLC (5.52M shares), Darwin Global Management, Ltd. (3.92M shares), Frazier Life Sciences Management, L.P. (3.46M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.89M shares), RTW INVESTMENTS, LP (2.85M shares), NEA Management Company, LLC (2.69M shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (2.32M shares), WELLINGTON MANAGEMENT GROUP LLP (2.13M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.87M shares).
This table shows the top 258 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.